Index by author

July 15, 2024; Volume 21,Issue 7

  1. An, Liwei

    1. Open Access
      Modeling human gastric cancers in immunocompetent mice
      Weihong Zhang, Shilong Wang, Hui Zhang, Yan Meng, Shi Jiao, Liwei An and Zhaocai Zhou
      Cancer Biology & Medicine July 2024, 21 (7) 553-570; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0124

  2. Ba, Yi

    1. Open Access
      Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer
      Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie and Yi Ba
      Cancer Biology & Medicine July 2024, 21 (7) 636-650; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0301

  3. Bai, Ming

    1. Open Access
      Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer
      Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie and Yi Ba
      Cancer Biology & Medicine July 2024, 21 (7) 636-650; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0301

  4. Cao, Liu

    1. Open Access
      Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research
      Xiaoyu Song, Xiyan Liu, Qiqiang Guo, Hongde Xu and Liu Cao
      Cancer Biology & Medicine July 2024, 21 (7) 541-546; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0157

  5. Dong, Haoran

    1. Open Access
      ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis
      Shirong Tan, Xiangyu Sun, Haoran Dong, Mozhi Wang, Litong Yao, Mengshen Wang, Ling Xu and Yingying Xu
      Cancer Biology & Medicine July 2024, 21 (7) 606-635; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0309

  6. Fu, Yubin

    1. Open Access
      Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei
      Qidi Zhao, Tian Wei, Ru Ma, Yubin Fu, Rui Yang, Yandong Su, Yang Yu, Bing Li and Yan Li
      Cancer Biology & Medicine July 2024, 21 (7) 586-605; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0109

  7. Guo, Qiqiang

    1. Open Access
      Unraveling the nexus between cellular senescence and malignant transformation: a paradigm shift in cancer research
      Xiaoyu Song, Xiyan Liu, Qiqiang Guo, Hongde Xu and Liu Cao
      Cancer Biology & Medicine July 2024, 21 (7) 541-546; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0157

  8. Huang, Chenghui

    1. Open Access
      Phase Ib study of anti-EGFR antibody (SCT200) in combination with anti-PD-1 antibody (SCT-I10A) for patients with RAS/BRAF wild-type metastatic colorectal cancer
      Ming Bai, Yao Lu, Chunmei Shi, Jianwei Yang, Wei Li, Xianli Yin, Chenghui Huang, Lin Shen, Liangzhi Xie and Yi Ba
      Cancer Biology & Medicine July 2024, 21 (7) 636-650; DOI: https://doi.org/10.20892/j.issn.2095-3941.2023.0301

  9. Jiao, Shi

    1. Open Access
      Modeling human gastric cancers in immunocompetent mice
      Weihong Zhang, Shilong Wang, Hui Zhang, Yan Meng, Shi Jiao, Liwei An and Zhaocai Zhou
      Cancer Biology & Medicine July 2024, 21 (7) 553-570; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0124

  10. Li, Bing

    1. Open Access
      Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei
      Qidi Zhao, Tian Wei, Ru Ma, Yubin Fu, Rui Yang, Yandong Su, Yang Yu, Bing Li and Yan Li
      Cancer Biology & Medicine July 2024, 21 (7) 586-605; DOI: https://doi.org/10.20892/j.issn.2095-3941.2024.0109
« Previous (Pages : 1 2 3 4 5 ... 5) Next »
Back to top

In this issue

Cancer Biology & Medicine: 21 (7)
Cancer Biology & Medicine
Vol. 21, Issue 7
15 Jul 2024

Submit

Sign up for alerts